Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of Pharmaceutical Sciences|May 7, 2011
Estimated pKa values for specific amino acid residues in daptomycinJiang Qiu, Liping Yu, Lee E Kirsch
AAPS Pharmscitech|August 18, 2018
Particle Size Distribution Equivalency as Novel Predictors for BioequivalencePratak Ngeacharernkul, Stephen D Stamatis, Lee E Kirsch
Journal of Pharmaceutical Sciences|April 23, 2015
A Novel Method for Assessing Drug Degradation Product Safety Using Physiologically-Based Pharmacokinetic Models and Stochastic Risk AssessmentHoa Q Nguyen, Stephen D Stamatis, Lee E Kirsch
PDA Journal of Pharmaceutical Science and Technology|February 10, 2004
Characterization methods for the physical stability of biopharmaceuticalsLida T Nguyen, John M Wiencek, Lee E Kirsch
AAPS Pharmscitech|March 24, 2009
Glycosylation of aromatic amines I: Characterization of reaction products and kinetic schemeMadhushree Y Gokhale, William R Kearney, Lee E Kirsch
Journal of Pharmaceutical Sciences|March 16, 2012
Kinetic model for solid-state degradation of gabapentinZhixin Zong, Jiang Qiu, Radaduen Tinmanee, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 27, 2017
Quantification of gabapentin polymorphs in gabapentin/excipient mixtures using solid state 13C NMR spectroscopy and X-ray powder diffractionRadaduen Tinmanee, Sarah C Larsen, Kenneth R Morris, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|February 20, 2015
The interaction mechanism between lipopeptide (daptomycin) and polyamidoamine (PAMAM) dendrimersBoontarika Chanvorachote, Jiang Qiu, Walaisiri Muangsiri, et al.
Journal of Pharmaceutical Sciences|July 30, 2005
Studies on the mechanism of aspartic acid cleavage and glutamine deamidation in the acidic degradation of glucagonAnjali B Joshi, Monali Sawai, William R Kearney, et al.
Pageof 3